Legato Capital Management »

Peregrine Pharmaceuticals shares owned by Legato Capital Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 257k 6.70
2023-12-31 $1.4M 220k 6.50
2023-09-30 $2.1M 220k 9.44
2023-06-30 $3.9M 276k 13.97
2023-03-31 $713k 38k 18.76
2022-12-31 $792k 58k 13.77
2022-09-30 $4.4M 228k 19.12
2022-06-30 $4.3M 282k 15.26
2022-03-31 $4.7M 231k 20.37
2021-12-31 $6.7M 231k 29.18
2021-09-30 $6.6M 305k 21.57
2021-06-30 $8.7M 340k 25.65
2021-03-31 $6.4M 353k 18.23
2020-12-31 $4.8M 416k 11.54
2020-09-30 $3.5M 460k 7.62
2020-06-30 $2.7M 413k 6.57
2020-03-31 $2.1M 413k 5.11
2019-12-31 $3.2M 420k 7.67
2019-09-30 $2.1M 420k 5.04
2019-06-30 $2.3M 420k 5.60
2019-03-31 $1.7M 396k 4.25
2018-12-31 $975k 238k 4.10